Making an Impossible Mission Possible

Sergio L. Kobal; Lawrence S.C. Czer; Peter C. Czer; Zhanna Feldsher; Robert Hamilton; Robert J. Siegel

doi:10.1378/chest.125.1.293

Making an Impossible Mission Possible

Sergio L. Kobal, Lawrence S.C. Czer, Peter C. Czer, Zhanna Feldsher, Robert Hamilton, Robert J. Siegel

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Cardiovascular disease (CVD) is widespread in developing countries. Hypertension is a major contributor of CVD. Left ventricular hypertrophy (LVH) is a risk marker in hypertensive populations. Identification of LVH and treatment of high-risk patients can result in more effective use of the limited resources. LVH is diagnosed by echfocardiography, often unavailable in developing countries. In Gambia, we used a hand-carried ultrasound (HCU) to examine 1,997 people. Seventeen percent had hypertension; of these, LVH was found in 65%. The battery-powered HCU permits clinicians to detect LVH in areas with limited access to diagnostic equipment, allowing identification of a high-risk hypertensive population.

Original language	English
Pages (from-to)	293-296
Number of pages	4
Journal	Chest
Volume	125
Issue number	1
DOIs	https://doi.org/10.1378/chest.125.1.293
State	Published - 1 Jan 2004
Externally published	Yes

Keywords

Cardiovascular disease
Developing countries
Hand-carried cardiac ultrasound
Hypertension
Risk stratification

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine
Critical Care and Intensive Care Medicine
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1378/chest.125.1.293

Cite this

@article{b4f0eddaf55f49a7b00cb34ba74ffcb5,

title = "Making an Impossible Mission Possible",

abstract = "Cardiovascular disease (CVD) is widespread in developing countries. Hypertension is a major contributor of CVD. Left ventricular hypertrophy (LVH) is a risk marker in hypertensive populations. Identification of LVH and treatment of high-risk patients can result in more effective use of the limited resources. LVH is diagnosed by echfocardiography, often unavailable in developing countries. In Gambia, we used a hand-carried ultrasound (HCU) to examine 1,997 people. Seventeen percent had hypertension; of these, LVH was found in 65\%. The battery-powered HCU permits clinicians to detect LVH in areas with limited access to diagnostic equipment, allowing identification of a high-risk hypertensive population.",

keywords = "Cardiovascular disease, Developing countries, Hand-carried cardiac ultrasound, Hypertension, Risk stratification",

author = "Kobal, \{Sergio L.\} and Czer, \{Lawrence S.C.\} and Czer, \{Peter C.\} and Zhanna Feldsher and Robert Hamilton and Siegel, \{Robert J.\}",

year = "2004",

month = jan,

day = "1",

doi = "10.1378/chest.125.1.293",

language = "English",

volume = "125",

pages = "293--296",

journal = "Chest",

issn = "0012-3692",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Making an Impossible Mission Possible

AU - Kobal, Sergio L.

AU - Czer, Lawrence S.C.

AU - Czer, Peter C.

AU - Feldsher, Zhanna

AU - Hamilton, Robert

AU - Siegel, Robert J.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Cardiovascular disease (CVD) is widespread in developing countries. Hypertension is a major contributor of CVD. Left ventricular hypertrophy (LVH) is a risk marker in hypertensive populations. Identification of LVH and treatment of high-risk patients can result in more effective use of the limited resources. LVH is diagnosed by echfocardiography, often unavailable in developing countries. In Gambia, we used a hand-carried ultrasound (HCU) to examine 1,997 people. Seventeen percent had hypertension; of these, LVH was found in 65%. The battery-powered HCU permits clinicians to detect LVH in areas with limited access to diagnostic equipment, allowing identification of a high-risk hypertensive population.

AB - Cardiovascular disease (CVD) is widespread in developing countries. Hypertension is a major contributor of CVD. Left ventricular hypertrophy (LVH) is a risk marker in hypertensive populations. Identification of LVH and treatment of high-risk patients can result in more effective use of the limited resources. LVH is diagnosed by echfocardiography, often unavailable in developing countries. In Gambia, we used a hand-carried ultrasound (HCU) to examine 1,997 people. Seventeen percent had hypertension; of these, LVH was found in 65%. The battery-powered HCU permits clinicians to detect LVH in areas with limited access to diagnostic equipment, allowing identification of a high-risk hypertensive population.

KW - Cardiovascular disease

KW - Developing countries

KW - Hand-carried cardiac ultrasound

KW - Hypertension

KW - Risk stratification

UR - http://www.scopus.com/inward/record.url?scp=1642452874&partnerID=8YFLogxK

U2 - 10.1378/chest.125.1.293

DO - 10.1378/chest.125.1.293

M3 - Article

AN - SCOPUS:1642452874

SN - 0012-3692

VL - 125

SP - 293

EP - 296

JO - Chest

JF - Chest

IS - 1

ER -

Making an Impossible Mission Possible

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this